GLyPharma Therapeutic Report issue

For profit Phase 2
Founded: Montreal Canada (2012)
Status: Acquired by Therachon (2018) → now Pfizer (2019)

Organization Overview

First Clinical Trial
2018
NCT03408132
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

GLyPharma Therapeutic